Blockchain Registration Transaction Record

OMRON Marks 40 Years of Ohasama Study for World Heart Day

OMRON Healthcare celebrates 40 years of the Ohasama Study, which established home blood pressure monitoring as key to hypertension management and preventive care.

The Ohasama Study's 40-year legacy has fundamentally changed how hypertension is managed worldwide. By proving that home blood pressure readings are stronger predictors of cardiovascular outcomes than clinic measurements, it empowered individuals to take control of their heart health and gave healthcare professionals a more accurate tool for diagnosis and treatment. This shift has likely contributed to reduced rates of stroke, heart attack, and other cardiovascular events. As cardiovascular disease remains the leading cause of death globally, the study's ongoing research into early biomarkers and preventive strategies offers hope for even earlier interventions. OMRON's continued commitment to preventive care, including atrial fibrillation detection, means that patients and families can benefit from innovations that save lives. Ultimately, this milestone is a testament to the power of long-term collaboration and evidence-based innovation in improving public health.